These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36339006)

  • 1. Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma.
    Lu Q; Liu L; Wang S; Zhang Q; Li L
    Front Genet; 2022; 13():990594. PubMed ID: 36339006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
    Xiao Y; Li J; Wu J
    BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of m
    Wu X; Wang S; Wu X; Chen Q; Cheng J; Qi Z
    J Cancer; 2024; 15(7):2045-2065. PubMed ID: 38434979
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma.
    Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K
    Front Immunol; 2021; 12():800268. PubMed ID: 34956238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.
    Chen X; Sun M; Feng W; Chen J; Ji X; Xie M; Huang W; Chen X; Zhang B; Nie Y; Fan D; Wu K; Xia L
    Front Genet; 2023; 14():1056000. PubMed ID: 36845390
    [No Abstract]   [Full Text] [Related]  

  • 6. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma.
    He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D
    Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of nine m7G-related lncRNAs as prognosis factors in tumor immune microenvironment of hepatocellular carcinoma and experimental validation.
    Wang T; Zhou Z; Wang X; You L; Li W; Zheng C; Zhang J; Wang L; Kong X; Gao Y; Sun X
    Front Genet; 2022; 13():929035. PubMed ID: 36081998
    [No Abstract]   [Full Text] [Related]  

  • 8. Construction of a m5C-related long non-coding RNA signature for the prognosis of hepatocellular carcinoma.
    Lu J; Wang H; Cao W; Chen D; He Z; Xu J
    Hum Cell; 2023 Mar; 36(2):712-724. PubMed ID: 36520346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of a novel prognosis model based on m5C-related long non-coding RNAs in colorectal cancer.
    Di Z; Xu G; Ding Z; Li C; Song J; Huang G; Zheng J; Zhang X; Xiong B
    Cancer Cell Int; 2023 Sep; 23(1):196. PubMed ID: 37670275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic signature and immune landscape of 5-methylcytosine-related long non-coding RNAs in gastric cancer.
    Song Q; Wu J; Wan H; Fan D
    Heliyon; 2024 Sep; 10(18):e37290. PubMed ID: 39323814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of m5C regulatory genes in hepatocellular carcinoma.
    Yang X; Yang F; Lan L; Wen N; Li H; Sun X
    Front Genet; 2022; 13():972043. PubMed ID: 36105093
    [No Abstract]   [Full Text] [Related]  

  • 12. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM; Ma N; Ma T; Zhou JY; Yang WS; Liu CX; Hou ZH; Chen S; Zong Z; Zeng B; Li YR; Zhou TC
    World J Gastrointest Oncol; 2022 Oct; 14(10):1981-2003. PubMed ID: 36310708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall Survival Signature of 5-Methylcytosine Regulators Related Long Non-Coding RNA in Hepatocellular Carcinoma.
    Pan Q; Yi C; Zhang Y
    Front Oncol; 2022; 12():884377. PubMed ID: 35686101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma.
    Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H
    BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
    Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
    Front Immunol; 2022; 13():918140. PubMed ID: 35833147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signature of m5C-Related lncRNA for Prognostic Prediction and Immune Responses in Pancreatic Cancer.
    Liu X; Wang D; Han S; Wang F; Zang J; Xu C; Dong X
    J Oncol; 2022; 2022():7467797. PubMed ID: 35211172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of Prognostic Risk Model of 5-Methylcytosine-Related Long Non-Coding RNAs and Evaluation of the Characteristics of Tumor-Infiltrating Immune Cells in Breast Cancer.
    Huang Z; Li J; Chen J; Chen D
    Front Genet; 2021; 12():748279. PubMed ID: 34777473
    [No Abstract]   [Full Text] [Related]  

  • 20. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
    Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.